JP2024509877A5 - - Google Patents
Info
- Publication number
- JP2024509877A5 JP2024509877A5 JP2023554343A JP2023554343A JP2024509877A5 JP 2024509877 A5 JP2024509877 A5 JP 2024509877A5 JP 2023554343 A JP2023554343 A JP 2023554343A JP 2023554343 A JP2023554343 A JP 2023554343A JP 2024509877 A5 JP2024509877 A5 JP 2024509877A5
- Authority
- JP
- Japan
- Prior art keywords
- chromatography
- column
- pool
- polish
- unit operations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163159217P | 2021-03-10 | 2021-03-10 | |
| US63/159,217 | 2021-03-10 | ||
| PCT/US2022/019697 WO2022192504A1 (en) | 2021-03-10 | 2022-03-10 | Methods for purification of recombinant proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024509877A JP2024509877A (ja) | 2024-03-05 |
| JP2024509877A5 true JP2024509877A5 (enExample) | 2025-03-10 |
Family
ID=80952165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023554343A Pending JP2024509877A (ja) | 2021-03-10 | 2022-03-10 | 組換えタンパク質の精製方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240051990A1 (enExample) |
| EP (1) | EP4305048A1 (enExample) |
| JP (1) | JP2024509877A (enExample) |
| KR (1) | KR20230154908A (enExample) |
| CN (1) | CN117043173A (enExample) |
| AU (1) | AU2022234768A1 (enExample) |
| CA (1) | CA3209216A1 (enExample) |
| IL (1) | IL304571A (enExample) |
| WO (1) | WO2022192504A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL322843A (en) * | 2023-03-14 | 2025-10-01 | Amgen Inc | Anion exchange chromatography processes using a primary amine ligand |
| TW202515647A (zh) * | 2023-06-20 | 2025-04-16 | 美商安進公司 | 用於層析和層析介質再利用之方法 |
| WO2025262319A1 (en) * | 2024-06-21 | 2025-12-26 | Boehringer Ingelheim International Gmbh | Modifying blue color formation in bioprocesses |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7112324B1 (en) | 1998-04-21 | 2006-09-26 | Micromet Ag | CD 19×CD3 specific polypeptides and uses thereof |
| MXPA06004035A (es) | 2003-10-16 | 2006-08-31 | Micromet Ag | Aglutinantes cd3 de-inmunizados multi-especificos. |
| RS53008B2 (sr) | 2007-04-03 | 2022-12-30 | Amgen Res Munich Gmbh | Interspecijski specifičan cd3-epsilon vezujući domen |
| MX353382B (es) | 2012-03-01 | 2018-01-10 | Amgen Res Munich Gmbh | Moleculas de union polipeptido de larga duracion. |
| EP2656892A1 (en) * | 2012-04-23 | 2013-10-30 | Merck Patent GmbH | Chromatography method |
| AU2014226126B2 (en) * | 2013-03-08 | 2019-02-14 | Genzyme Corporation | Continuous purification of therapeutic proteins |
| US20140308285A1 (en) | 2013-03-15 | 2014-10-16 | Amgen Inc. | Heterodimeric bispecific antibodies |
| US11634502B2 (en) | 2013-03-15 | 2023-04-25 | Amgen Inc. | Heterodimeric bispecific antibodies |
| PL2970449T3 (pl) | 2013-03-15 | 2020-04-30 | Amgen Research (Munich) Gmbh | Jednołańcuchowe cząsteczki wiążące zawierające N-końcowy ABP |
| US20140302037A1 (en) | 2013-03-15 | 2014-10-09 | Amgen Inc. | BISPECIFIC-Fc MOLECULES |
| US20160257748A1 (en) | 2013-09-25 | 2016-09-08 | Amgen Inc. | V-c-fc-v-c antibody |
| EA039859B1 (ru) | 2015-07-31 | 2022-03-21 | Эмджен Рисерч (Мюник) Гмбх | Биспецифические конструкты антител, связывающие egfrviii и cd3 |
-
2022
- 2022-03-10 JP JP2023554343A patent/JP2024509877A/ja active Pending
- 2022-03-10 EP EP22713202.4A patent/EP4305048A1/en active Pending
- 2022-03-10 CA CA3209216A patent/CA3209216A1/en active Pending
- 2022-03-10 KR KR1020237033301A patent/KR20230154908A/ko active Pending
- 2022-03-10 US US18/268,772 patent/US20240051990A1/en active Pending
- 2022-03-10 AU AU2022234768A patent/AU2022234768A1/en active Pending
- 2022-03-10 WO PCT/US2022/019697 patent/WO2022192504A1/en not_active Ceased
- 2022-03-10 CN CN202280019599.6A patent/CN117043173A/zh active Pending
-
2023
- 2023-07-19 IL IL304571A patent/IL304571A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024509877A5 (enExample) | ||
| RU2461564C2 (ru) | Способ очистки циклического или нециклического пептида | |
| DK171917B1 (da) | Forbindelser, der kan anvendes til rensning af proteiner og fremgangsmåder, der anvender disse forbindelser | |
| EP1571208B1 (en) | Novel factor IX purification methods | |
| JP2023537565A5 (enExample) | ||
| CN115768888A (zh) | 单链rna的纯化方法 | |
| US6001974A (en) | Method of separating albumin from serum by ion-exchange chromatography with membrane adsorbers | |
| CN106170493A (zh) | 促性腺激素的新型纯化方法 | |
| JP6232130B2 (ja) | ダルベポエチンアルファの精製方法 | |
| KR20190076046A (ko) | 단백질 용액의 탈염 공정 | |
| CN1175105C (zh) | 借助于膜色谱进行的维生素k依赖性蛋白的纯化 | |
| Fortis et al. | A new approach for the removal of protein impurities from purified biologicals using combinatorial solid‐phase ligand libraries | |
| JP2573467B2 (ja) | 第ｉｘ因子タンパク質を含有する治療用途に適した薬剤的組成物 | |
| UA46005C2 (uk) | Спосіб одержання фактора ix із біологічних джерел та фактор, одержаний вказаним способом | |
| JP7457023B2 (ja) | インスリンアナログの精製のためのクロマトグラフィープロセス | |
| KR20140033126A (ko) | 단일 유닛 크로마토그래피 항체 정제 | |
| Mikulski et al. | Large scale purification of human fibroblast interferon | |
| KR101941974B1 (ko) | 혈장 단백질 정제시 fxi의 제거방법 | |
| EP4408561B1 (en) | Purification method and uses thereof | |
| CN114096558B (zh) | 纯化c1-inh的方法 | |
| KR20240135017A (ko) | 생물학적 제제를 정제하는 프로세스 중 오염물질의 선택적 제거를 위한 방법 | |
| TW201900257A (zh) | 使用親和力層析術純化抗體或其抗體片段的方法 | |
| RU2025474C1 (ru) | Способ получения s-сульфоната проинсулина | |
| TWI612056B (zh) | 自非乙醯化蛋白質分離乙醯化蛋白質 | |
| KR20250025373A (ko) | 하류 항체 정제에서 uf/df 풀로부터의 집합체의 클리어런스 |